238 related articles for article (PubMed ID: 15967011)
1. [Maintenance treatment and early intervention--the new paradigm in the management of atopic eczema].
Korting HC
J Dtsch Dermatol Ges; 2005 Jul; 3(7):519-23. PubMed ID: 15967011
[No Abstract] [Full Text] [Related]
2. [Calcineurin inhibitors in treatment of atopic dermatitis. Topical corticoids now only in severe outbreaks? ].
MMW Fortschr Med; 2003 Jul; 145(29-30):62. PubMed ID: 12958787
[No Abstract] [Full Text] [Related]
3. Topical treatments with pimecrolimus, tacrolimus and medium- to high-potency corticosteroids, and risk of lymphoma.
Schneeweiss S; Doherty M; Zhu S; Funch D; Schlienger RG; Fernandez-Vidaurre C; Seeger JD
Dermatology; 2009; 219(1):7-21. PubMed ID: 19293564
[TBL] [Abstract][Full Text] [Related]
4. [Therapy of atopic eczema with calcineurin inhibitors].
Luger TA; Bieber T; Meurer M; Mrowietz U; Schwarz T; Simon J; Werfel T; Zuberbier T
J Dtsch Dermatol Ges; 2005 May; 3(5):385-91. PubMed ID: 16372807
[No Abstract] [Full Text] [Related]
5. The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force.
Berger TG; Duvic M; Van Voorhees AS; VanBeek MJ; Frieden IJ;
J Am Acad Dermatol; 2006 May; 54(5):818-23. PubMed ID: 16635663
[No Abstract] [Full Text] [Related]
6. Atopic dermatitis in children in the United States, 1997-2004: visit trends, patient and provider characteristics, and prescribing patterns.
Horii KA; Simon SD; Liu DY; Sharma V
Pediatrics; 2007 Sep; 120(3):e527-34. PubMed ID: 17766497
[TBL] [Abstract][Full Text] [Related]
7. Clinical management of atopic eczema with pimecrolimus cream 1% (Elidel) in paediatric patients.
Eichenfield LF; Thaci D; de Prost Y; Puig L; Paul C
Dermatology; 2007; 215 Suppl 1():3-17. PubMed ID: 18174689
[TBL] [Abstract][Full Text] [Related]
8. [Topical calcineurin inhibitors in atopic eczema -- contra].
Abeck D
Dtsch Med Wochenschr; 2006 Jul; 131(28-29):1615. PubMed ID: 16823714
[No Abstract] [Full Text] [Related]
9. The role of pimecrolimus cream 1% (Elidel)) in managing adult atopic eczema.
Meurer M; Lubbe J; Kapp A; Schneider D
Dermatology; 2007; 215 Suppl 1():18-26. PubMed ID: 18174690
[TBL] [Abstract][Full Text] [Related]
10. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
[TBL] [Abstract][Full Text] [Related]
11. Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis.
Ingram JR; Martin JA; Finlay AY
Am J Clin Dermatol; 2009; 10(4):229-37. PubMed ID: 19489656
[TBL] [Abstract][Full Text] [Related]
12. Report of the Topical Calcineurin Inhibitor Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology.
Fonacier L; Spergel J; Charlesworth EN; Weldon D; Beltrani V; Bernhisel-Broadbent J; Boguniewicz M; Leung DY; ;
J Allergy Clin Immunol; 2005 Jun; 115(6):1249-53. PubMed ID: 15940142
[No Abstract] [Full Text] [Related]
13. [Topical calcineurin inhibitors in atopic eczema -- pro].
Wollenberg A
Dtsch Med Wochenschr; 2006 Jul; 131(28-29):1614. PubMed ID: 16823713
[No Abstract] [Full Text] [Related]
14. Topical tacrolimus in the management of atopic dermatitis in Japan.
Furue M; Uchi H; Moroi Y; Ogawa S; Nakahara T; Urabe K
Dermatol Ther; 2006; 19(2):118-26. PubMed ID: 16669995
[TBL] [Abstract][Full Text] [Related]
15. [Guidelines for the management of atopic dermatitis 2006].
Yamamoto S
Arerugi; 2008 Nov; 57(11):1103-8. PubMed ID: 19052504
[No Abstract] [Full Text] [Related]
16. A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis.
Neumann E; Amtage D; Bruckner-Tuderman L; Mockenhaupt M
J Dtsch Dermatol Ges; 2008 Jul; 6(7):548-53. PubMed ID: 18248495
[TBL] [Abstract][Full Text] [Related]
17. Topical treatment of atopic dermatitis.
Boguniewicz M
Immunol Allergy Clin North Am; 2004 Nov; 24(4):631-44, vi-vii. PubMed ID: 15474863
[TBL] [Abstract][Full Text] [Related]
18. An update on the safety and tolerability of pimecrolimus cream 1%: evidence from clinical trials and post-marketing surveillance.
Langley RG; Luger TA; Cork MJ; Schneider D; Paul C
Dermatology; 2007; 215 Suppl 1():27-44. PubMed ID: 18174691
[TBL] [Abstract][Full Text] [Related]
19. [Post-marketing surveillance on treatment of 5,665 patients with atopic dermatitis using the calcineurin inhibitor pimecrolimus: positive effects on major symptoms of atopic dermatitis and on quality of life].
Sunderkötter C; Weiss JM; Bextermöller R; Löffler H; Schneider D
J Dtsch Dermatol Ges; 2006 Apr; 4(4):301-6. PubMed ID: 16638059
[TBL] [Abstract][Full Text] [Related]
20. [Local treatment of atopic dermatitis with calcineurin inhibitors].
Langeland T
Tidsskr Nor Laegeforen; 2006 Jan; 126(3):321-2. PubMed ID: 16440040
[No Abstract] [Full Text] [Related]
[Next] [New Search]